Sionc Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 13.00 Cr
- Paid Up Capital ₹ 12.58 Cr
- Company Age 17 Year,
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 133.51 Cr
- Satisfied Charges ₹ 59.73 Cr
- Revenue Growth 23.68%
- Profit Growth 66.34%
- Ebitda 46.49%
- Net Worth 22.39%
- Total Assets 29.68%
About Sionc Pharmaceuticals
Sionc Pharmaceuticals Private Limited (SPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 01 February 2008 and has a history of 17 years. Its registered office is in Visakhapatnam, Andhra Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 13.00 Cr and a paid-up capital of Rs 12.58 Cr.
The company currently has active open charges totaling ₹133.51 Cr. The company has closed loans amounting to ₹59.73 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sionc Pharmaceuticals Private Limited India is Suman Lahoti as COMPANY SECRETARY. Baburao Dandamudi, Jagadeesh Rangisetty, Manikreddy Pullagurla, and Two other members serve as directors at the Company.
Company Details
-
Location
Visakhapatnam, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232AP2008PTC057417
-
Company No.
057417
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Feb 2008
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Sionc Pharmaceuticals?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Baburao Dandamudi
|
Managing Director | 01-Feb-2008 | Current |
| Suman Lahoti | Company Secretary | 01-Feb-2022 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Jagadeesh Rangisetty
|
Director | 01-Feb-2008 | Current |
|
Manikreddy Pullagurla
|
Director | 21-May-2009 | Current |
|
Srikanth Dandamudi
|
Director | 21-May-2009 | Current |
|
Subba Jetti
|
Director | 01-Dec-2011 | Current |
Financial Performance of Sionc Pharmaceuticals.
Sionc Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 23.68% increase. The company also saw a substantial improvement in profitability, with a 66.34% increase in profit. The company's net worth Soared by an impressive increase of 22.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sionc Pharmaceuticals?
In 2023, Sionc Pharmaceuticals had a promoter holding of 37.91% and a public holding of 62.09%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Azico Biophore India Private LimitedJagadeesh Rangisetty and Manikreddy Pullagurla are mutual person
-
Leiutis Pharmaceuticals LlpJagadeesh Rangisetty and Manikreddy Pullagurla are mutual person
-
Biophore India Pharmaceuticals Private LimitedJagadeesh Rangisetty and Manikreddy Pullagurla are mutual person
-
Zenara Pharma Private Limited
Jagadeesh Rangisetty and Manikreddy Pullagurla are mutual person
-
Alithia Pharmaceuticals Private Limited
Jagadeesh Rangisetty and Manikreddy Pullagurla are mutual person
-
Susi Sea Foods Private LimitedBaburao Dandamudi is a mutual person
Charges (Loans)
₹133.51 Cr
₹59.73 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 103.51 Cr
- Others : 30.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Sep 2024 | Others | ₹30.00 Cr | Open |
| 14 Mar 2023 | Hdfc Bank Limited | ₹2.97 M | Open |
| 25 Nov 2022 | Hdfc Bank Limited | ₹3.35 M | Open |
| 25 Nov 2021 | Hdfc Bank Limited | ₹102.88 Cr | Open |
| 11 Dec 2020 | Others | ₹7.38 Cr | Satisfied |
How Many Employees Work at Sionc Pharmaceuticals?
Sionc Pharmaceuticals has a workforce of 324 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sionc Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sionc Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.